metsera glp 1 Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo Metsera: An Emerging Contender In

Glucose control and insulin sensitivity: It enhances insulin secretion in response to glucose while reducing glucagon output, helping stabilise blood sugar and prevent energy crashes that drive hunger

Accidents happen all the time and few are truly prepared to do what it takes to secure their well-being

Undiagnosed thyroid issues are one of the most common reasons people can't lose weight

The strongest evidence compares how far medications can take you versus how much the body can be reset through metabolic surgery

However, if you use an insulin pump, youll likely need to adjust your insulin doses to avoid low blood sugar as your body responds to this new medication